-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Maintains Buy on Elevance Health, Lowers Price Target to $391

Benzinga·04/20/2026 17:07:41
Listen to the news
Jefferies analyst David Windley maintains Elevance Health (NYSE:ELV) with a Buy and lowers the price target from $395 to $391.